PMID: 9425658Jan 13, 1998Paper

The impact of pharmacogenetics on the future of healthcare

Current Opinion in Biotechnology
J B Lichter, J H Kurth

Abstract

Pharmacogenetics has been promoted as potentially providing benefits to patients, managed care organizations and pharmaceutical companies. This has not translated into products that benefit healthcare developers, providers or consumers. The reasons for this are many, but this will change as the financial incentives become clear for the pharmaceutical industry to develop products that use genetic susceptibility as part of the rationale for products, healthcare providers have increasing incentive to reduce costs, and patients demand up-to-date technologies to optimize healthcare. Recent studies have established genetic contributions that alter the response to therapy for some disease entities, and more will follow as pharmacogenetics becomes increasingly accepted as an important consideration in the therapeutic decision-making process.

References

Dec 1, 1995·Current Opinion in Biotechnology·J Lichter, D McNamara
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·J PoirierS Gauthier
Jul 25, 1996·The New England Journal of Medicine·A D'AngeloS V D'Angelo
Jul 1, 1996·Journal of the American Academy of Dermatology·M J Rothe, J M Grant-Kels
Dec 16, 1996·Annals of the New York Academy of Sciences·M R FarlowS Hui

❮ Previous
Next ❯

Citations

Jul 25, 2000·Journal of Clinical Pharmacy and Therapeutics·N PoolsupT L Knight
Dec 16, 2005·Pharmacogenomics·Anja RogauschWolfgang Himmel
Nov 23, 2006·Diabetes Research and Clinical Practice·Huijuan ZhangHouxun Xing
Sep 19, 2006·Studies in History and Philosophy of Biological and Biomedical Sciences·Andrew Smart, Paul Martin
Dec 14, 2001·AAPS PharmSci·D L VeenstraK A Phillips
Nov 19, 2003·Social Studies of Science·Adam Hedgecoe, Paul Martin
Jun 26, 2004·PharmacoEconomics·Christopher R Flowers, David Veenstra
Feb 24, 2001·Journal of Hypertension·S T TurnerE Boerwinkle
Apr 6, 2005·Journal of Biomolecular Screening·Rieko ArimotoEric M Gifford
Jun 10, 2010·Social Studies of Science·Adam Hedgecoe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.